APA (7th ed.) Citation

R, R., B, H., Z, S., N, H., M, Z., M, L., . . . S, E. (2026). Enzyme replacement therapy for CLN1 batten disease that crosses the blood-brain-barrier. Molecular genetics and metabolism, 147(3), 109733. https://doi.org/10.1016/j.ymgme.2026.109733

Chicago Style (17th ed.) Citation

R, Raman, et al. "Enzyme Replacement Therapy for CLN1 Batten Disease That Crosses the Blood-brain-barrier." Molecular Genetics and Metabolism 147, no. 3 (2026): 109733. https://doi.org/10.1016/j.ymgme.2026.109733.

MLA (9th ed.) Citation

R, Raman, et al. "Enzyme Replacement Therapy for CLN1 Batten Disease That Crosses the Blood-brain-barrier." Molecular Genetics and Metabolism, vol. 147, no. 3, 2026, p. 109733, https://doi.org/10.1016/j.ymgme.2026.109733.